Neoral: Precision Immunosuppression for Transplant and Autoimmune Disease - Evidence-Based Review

Product Description Neoral is an oral pharmaceutical formulation of cyclosporine, classified as an immunosuppressive agent. It is a critical medication in the field of transplant medicine and the treatment of certain severe autoimmune diseases. Unlike its predecessor, Sandimmune, Neoral is a microemulsion formulation designed to provide more consistent and predictable absorption of cyclosporine, a drug with a narrow therapeutic index. This improved pharmacokinetic profile is its defining characteristic, allowing for better management of drug levels and, consequently, improved efficacy and safety in long-term therapy.